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cardiac arrest
Kees H Polderman1* and Joseph Varon2,3,4Therapeutic hypothermia (TH) has been used to treat
post-hypoxic brain injury after cardiac arrest (CA) since
the late 1950s. In 2002, two landmark prospective, ran-
domized controlled trials (RCTs) confirmed the efficacy
of TH for this indication [1,2]. An 11-center trial in
Europe reported 16% absolute improvement in outcome
in patients with witnessed ventricular tachycardia/ven-
tricular fibrillation (VT/VF) arrest with use of TH [1],
and a four-center Australian study found 23% improve-
ment [2]. More than 40 non-randomized studies have
reported improved outcomes with TH [3]. A 5,317-pa-
tient registry in The Netherlands noted a 6.6% drop in
mortality with TH implementation [4]. A Scandinavian
registry with 986 patients reported 61% survival in wit-
nessed VT/VF arrest, 92% with good neurological out-
come [5]. A meta-analysis concluded that six patients
had to be treated to achieve one additional case of good
outcome [6]. On these bases, professional societies
began recommending the use of TH in selected patients
with CA [7,8]. A Cochrane Review supported these
guidelines and conclusions [9]. Further supporting evi-
dence came from the field of neonatology, in which
seven RCTs showed improved outcomes with TH in
newborns with hypoxic injury [3].
However, this evidence has been challenged [10]. The
largest RCT had no strict temperature management in
controls, who had an average temperature of 37.8°C [1].
Other criticisms included a lack of prior power calcula-
tion and a low rate of enrollment [10]. The second RCT
successfully maintained normothermia in controls, but
random assignment was by day of the month rather than
per patient [2]. The critics stimulated the conduct of an-
other, larger RCT, enrolling patients with witnessed CA
regardless of initial rhythm, with predefined subgroup
analyses [11]. This study enrolled 939 patients, who were* Correspondence: poldermankh@upmc.edu
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© BioMed Central Ltd.2014cooled to either 33°C or 36°C. The results were un-
equivocally negative.
These findings completely contradict those of all pre-
vious studies. Should we accept the results because the
study was well designed and larger than previous trials?
First, some important issues need to be clarified. TH
was already the standard of care in participating hospi-
tals, and the default option for patients not enrolled in
the trial was TH. Indeed, many centers had published
CA outcome data that were far better than those of this
study [5,12,13]. Hence, admitting physicians might sub-
consciously have selected patients with the potential to
benefit from receiving ‘routine’ TH rather than have
screened them for trial eligibility. The Methods section
[11] suggests that all patients were evaluated, but this
seems questionable: 1,431 patients were screened, and
939 were enrolled; that is an unusually high enrollment
rate of 66%. The study took place in 36 intensive care
units in just over 2 years, and this translates to 18 pa-
tients screened and 12 enrolled per center per year, or
one patient per center per month. This number seems
extremely low.
Other potential problems include a rapid rate of active
re-warming, from 33°C to 36°C in 6 hours, faster than in
all previous trials; this can negate the benefits of TH
[14,15]. The temperature graph, Figure 1 in the article
[11], shows wide error bars, potentially indicating large
temperature swings that can be harmful [14,15]. Also, it
appears that many ‘favorable’ factors such as bystander-
witnessed arrest and ‘shockable’ rhythm were more
prevalent in the 36°C group but that ‘unfavorable’ factors
such as circulatory shock and absence of pupillary and
corneal reflexes were more common in the 33°C group
[11]. The differences are small but may be cumulative.
There was a greater prevalence of spontaneous
hypothermia (before start of active cooling) in the 33°C
group, potentially indicating greater severity of brain in-
jury with diminished shivering response [14,15]. There
were more seizures in the 33°C group, in spite of the
well-recognized anti-seizure effects of hypothermia [3].
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withdrawal of care, again suggesting greater severity of
injury [11].
The consequences of accepting these conclusions are
momentous. We urge our colleagues not to abandon TH
in favor of strict fever management (or, worse, no
temperature management) on the basis of one study, until
all relevant issues have been satisfactorily addressed.
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